ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
ASSEMBLY BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$20.16+0.07 (+0.35%)
Close on Oct 19, 2026
- Market cap
- $380.09M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Assembly Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 22, 2026 | May 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 4, 2026 | Apr 22, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2026 | Mar 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 8, 2025 | Dec 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2025 | Aug 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2025 | Jun 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 9, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2025 | Apr 23, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2025 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2025 | Feb 20, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2024 | Jan 3, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 26, 2024 | Dec 26, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2024 | Dec 19, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2024 | Dec 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2024 | Sep 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2024 | Jun 18, 2024 | SEC EDGAR |
| Current report | 8-K | May 29, 2024 | Jun 3, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |